These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7922397)

  • 1. Platelet-activating factor in septic shock.
    Koltai M; Hosford D; Braquet PG
    New Horiz; 1993 Feb; 1(1):87-95. PubMed ID: 7922397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor: a potential mediator of shock.
    Braquet P; Paubert-Braquet M; Bessin P; Vargaftig BB
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17B():822-7. PubMed ID: 2960197
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet-activating factor and arachidonic acid metabolites mediate tumor necrosis factor and eicosanoid kinetics and cardiopulmonary dysfunction during bacteremic shock.
    Quinn JV; Slotman GJ
    Crit Care Med; 1999 Nov; 27(11):2485-94. PubMed ID: 10579269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet activating factor and its role in trauma, shock, and sepsis.
    Ayala A; Chaudry IH
    New Horiz; 1996 May; 4(2):265-75. PubMed ID: 8774801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects.
    Carrillo-Vico A; Lardone PJ; Naji L; Fernández-Santos JM; Martín-Lacave I; Guerrero JM; Calvo JR
    J Pineal Res; 2005 Nov; 39(4):400-8. PubMed ID: 16207296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of endotoxic shock.
    Villa P; Ghezzi P
    Methods Mol Med; 2004; 98():199-206. PubMed ID: 15064441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent ulcerogenic actions of platelet-activating factor on the stomach.
    Rosam AC; Wallace JL; Whittle BJ
    Nature; 1986 Jan 2-8; 319(6048):54-6. PubMed ID: 3510396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-induced lung vascular injury: role of platelet activating factor, tumor necrosis factor and neutrophils.
    Chang SW
    Clin Res; 1992 Oct; 40(3):528-36. PubMed ID: 1395440
    [No Abstract]   [Full Text] [Related]  

  • 9. Involvement of cytokines and platelet-activating factor in renal pathology.
    Camussi G; Tetta C; Bussolino F; Andres G; Turello E; Baglioni C
    J Lipid Mediat; 1990; 2 Suppl():S203-13. PubMed ID: 2133283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-1 receptor antagonist reduces mortality from endotoxin shock.
    Ohlsson K; Björk P; Bergenfeldt M; Hageman R; Thompson RC
    Nature; 1990 Dec; 348(6301):550-2. PubMed ID: 2147233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endotoxin-induced pulmonary leukostasis in the rat: role of platelet-activating factor and tumor necrosis factor.
    Chang SW
    J Lab Clin Med; 1994 Jan; 123(1):65-72. PubMed ID: 8288963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular mechanisms in sepsis.
    Jean-Baptiste E
    J Intensive Care Med; 2007; 22(2):63-72. PubMed ID: 17456726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.
    Koltai M; Hosford D; Braquet P
    J Lipid Mediat; 1993; 6(1-3):183-98. PubMed ID: 8357981
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential role of platelet-activating factor (PAF) in shock, sepsis and adult respiratory distress syndrome (ARDS).
    Braquet P; Hosford D
    Prog Clin Biol Res; 1989; 308():425-39. PubMed ID: 2675060
    [No Abstract]   [Full Text] [Related]  

  • 16. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Physiopathology of myocardial dysfunction in septic shock].
    Thyrault M; Chemla D; Coirault C; Lecarpentier Y
    Arch Mal Coeur Vaiss; 1993 Mar; 86(3):349-57. PubMed ID: 8215770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats.
    Balsa D; Merlos M; Giral M; Ferrando R; Garcia-Rafanell J; Forn J
    Drugs Exp Clin Res; 1997; 23(5-6):191-9. PubMed ID: 9515229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacterial endotoxins and their effects].
    Bertók L
    Orv Hetil; 1998 Aug; 139(33):1947-53. PubMed ID: 9734211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock.
    Beutler B
    New Horiz; 1993 Feb; 1(1):3-12. PubMed ID: 7922391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.